We want to thank all of the #doctors and Principal Investigators we get to work with to help us run our #clinicaltrials and provide #treatment options for #patients! They all are great supporters of our mission to solve the toughest challenges in #oncology 🩺
Recent Posts
- Recognizing Rare Disease Day
- Rethinking Radiation Therapy: A Targeted Approach for Hard‑to‑Treat Cancers
- Plus Therapeutics Announces Approval of New AMA Category III CPT® Code Supporting Use of Convection‑Enhanced Delivery with REYOBIQ™
- Navigating the Future of Radiopharmaceuticals
- Precision Medicine and the Next Wave of Innovation in CNS Cancers
Recent Comments